The FDA just approved a breakthrough drug for metastatic pancreatic cancer, which is notoriously hard to treat. In clinical trials, the new pill roughly doubled how long patients survived.
Copyright 2026 NPR
Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C.
